Jeffrey M. Jonas
Partner at Cure Ventures
About
A physician and CNS specialist with over two decades of R&D leadership experience in drug discovery and development. Held CEO roles at ABIO-X and Sage Therapeutics, where he led development of industry-leading CNS treatments. Author of over 300 peer-reviewed publications and holder of multiple patents in psychiatry and neuropharmacology.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeno Gyuris
Partner at Cure Ventures